GSK234072A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK234072A, covering 2017-08-04 to 2017-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old [Phase 2]